Loading provider…
Loading provider…
Infectious Disease Physician in Dallas, TX
NPI: 1083669543Primary Practice Location
BAYLOR UNIVERSITY MEDICAL CENTER
3500 Gaston Ave, Dallas, TX
Primary Employer
NORTH TEXAS INFECTIOUS DISEASES CONSULTANTS
HQ Phone
Get MD Christopher's Phone Numberphone_androidMobile
Get MD Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
AL State Medical License
TX State Medical License
2010 - 2026
AL State Medical License
2005 - 2010
VA State Medical License
2004 - 2006
IL State Medical License
2001 - 2005

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Infectious Disease
University of Alabama Medical Center
Fellowship • Infectious Disease
2008 - 2010
Loyola University Medical Center
Residency • Internal Medicine
2001 - 2004
St. George's University School of Medicine
Medical School
Until 2001
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 326 | 1,206 |
| 2 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 273 | 600 |
| 3 | J0897Injection, denosumab, 1 mg | 256 | 25,740 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 194 | 219 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 166 | 427 |
Authors: Scott Letendre, Franco Felizarta
Journal: J Antimicrob Chemother
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults.
Authors: Anthony Mills, Franco Felizarta, Debbie Hagins
Publication Date: 2019-06-13
Authors: Sumant Krishnan, Eddie Lo, Raffaele Garofalo
Journal: J Shoulder Elbow Surg
Publication Date: 2022-10-12
Lead Sponsor: ViiV Healthcare
Intervention / Treatment: BIOLOGICAL: GSK3810109A, BIOLOGICAL: Dolutegravir+lamivudine SOC regimen
Lead Sponsor: ViiV Healthcare
Collaborators: Janssen, LP
Intervention / Treatment: DRUG: Cabotegravir Tablets, DRUG: Rilpivirine Tablets, DRUG: Cabotegravir Injectable Suspension (CAB LA), DRUG: Rilpivirine Injectable Suspension (RPV LA), DRUG: BIKTARVY Tablets (BIK)
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Budigalimab, DRUG: ABBV-382, DRUG: Placebo for ABBV-382, DRUG: Placebo for Budigalimab